Skip to main content
. 2021 Oct 6;4(1):3–7. doi: 10.1002/acr2.11351

Table 1.

Characteristics of 243 survey respondents

Characteristics Results
Age, mean (SD), y 56.0 (14.5)
Gender, %
Man 18.1
Woman 81.5
Transgender 0.4
Race, %
White 66.7
Black 10.3
Asian 15.6
Other or choose not to answer 9.5
Latinx a 12.5
Primary language, %
English 91.8
Spanish 6.6
Other 1.7
Living situation, b %
Alone 17.7
Roommates 2.9
Partner/spouse 64.6
Children 34.6
Other family 13.6
Assisted living or skilled nursing facility 0.4
Total annual household income, a %
<$50 000 14.2
$50 000 to $100 000 24.3
$100 000 to >$200 000 57.7
Choose not to answer 17.2
Highest level of education, a %
High school graduate or less 7.4
Some college 16.5
College graduate 34.3
Postcollege degree 41.7
Systemic rheumatic disease, %
Rheumatoid arthritis 49.8
Systemic lupus erythematosus 27.6
Psoriatic arthritis 13.2
Other c 9.5
Rheumatic disease treatment, b %
None 12.4
Conventional synthetic DMARD 60.1
TNF inhibitor 18.5
Other biologic 14.0
JAK inhibitor 9.9
Glucocorticoid 16.5
Self‐reported comorbidities, %
Cancer 11.9
Lung disease 20.2
Chronic kidney disease 9.9
Coronary artery disease 4.1
Diabetes 9.5
Heart failure 2.9
Hypertension 34.6
Obesity 15.2
Stroke 5.8
Current smoker, % 2.5
Has a primary care doctor, a % 97.5
Always wears sunscreen, a % 51.3
Always wears a seatbelt, % 98.4

DMARD, disease‐modifying antirheumatic drug; JAK, Janus kinase; TNF, tumor necrosis factor.

a

Data were missing for Latinx (n = 3), income (n = 4), education (n = 1), primary care doctor (n = 1), and sunscreen (n = 5).

b

Categories are not mutually exclusive.

c

Inflammatory myositis (n = 7), scleroderma (n = 7), ankylosing spondylitis (n = 4), giant cell arteritis (n = 4), or polymyalgia rheumatica (n = 1).